Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Bayer AG NA (BAYGn)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
26.90 -0.08    -0.28%
11:28:40 - Closed. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Germany
ISIN:  DE000BAY0017 
WKN:  BAY001
  • Prev. Close: 26.90
  • Open: 27.09
  • Day's Range: 26.87 - 27.51
Bayer 26.90 -0.08 -0.28%

BAYGn Income Statement

 
Featured here, the Income Statement (earnings report) for Bayer AG NA, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Income Statement
Collapse All
Period Ending: 2023
31/12
 2023
30/09
 2023
30/06
 2023
31/03
Total Revenue 11862 10342 11044 14389
Revenue 11862 10342 11044 14389
Other Revenue, Total - - - -
Cost of Revenue, Total 4483 4812 4672 5733
Gross Profit 7379 5530 6372 8656
Total Operating Expenses 2486 13936 9510 11416
Selling/General/Admin. Expenses, Total 3373 3604 3557 4052
Research & Development 1534 1502 1376 1571
Depreciation / Amortization -1605 - - 395
Interest Expense (Income) - Net Operating - -467 -429 -327
Unusual Expense (Income) - - - -
Other Operating Expenses, Total -5299 4485 334 -8
Operating Income 9376 -3594 1534 2973
Interest Income (Expense), Net Non-Operating - - - -
Gain (Loss) on Sale of Assets -163 -3 - -47
Other, Net 7895 706 3108 414
Net Income Before Taxes 1644 -4297 -1574 2606
Provision for Income Taxes 302 280 315 424
Net Income After Taxes 1342 -4577 -1889 2182
Minority Interest 151 167 176 153
Equity In Affiliates - - - -
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items 1337 -4569 -1887 2178
Total Extraordinary Items - - - -
Net Income 1337 -4569 -1887 2178
Total Adjustments to Net Income - - - -
Income Available to Common Excluding Extraordinary Items 1337 -4569 -1887 2178
Dilution Adjustment -8.92 - -0.754 -2.97
Diluted Net Income 1345.92 -4569 -1886.25 2180.97
Diluted Weighted Average Shares 982.42 982.42 982.42 982.42
Diluted EPS Excluding Extraordinary Items 1.36 -4.65 -1.92 2.22
DPS - Common Stock Primary Issue 0.11 - - -
Diluted Normalized EPS 5.72 -2.72 0.585 1.68
* In Millions of EUR (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

BAYGn Comments

Write your thoughts about Bayer AG NA
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Alexander Zinchenko
Alexander Zinchenko Apr 20, 2024 12:31PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
still too high
Reply
0 0
Report
Luca ZeStonks
Luca ZeStonks Apr 17, 2024 7:05AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
STIFEL cut target price from 42 to 30 Euro. I changed my negative view and closed my positions and go long. ALWAYS do the opposite of what STIFEL recommends
Reply
5 0
Report
Crim Jamer
Crim Jamer Apr 17, 2024 7:05AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
played out well
Reply
0 0
Report
Luu Mrv
Luu Mrv Apr 15, 2024 2:01PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
is not matter of any results ! is matter of the lawsuit! that's all.
Reply
0 1
Report
Ovidiu Ivan
Ovidiu Ivan Apr 15, 2024 11:29AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
it is a very poor company. to much debt. The price is good if you believe that the new CEO will put the company towards a good destination. At this price you can risk some money and speculate that is going to deliver some decent results in Q1
Reply
0 1
Report
Luca ZeStonks
Luca ZeStonks Apr 15, 2024 11:29AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
first 24, then 20 euro and then 15 euro. Then at 15 you can buy if you believe the company doesnt go bankrupt
Reply
0 0
Report
Luca ZeStonks
Luca ZeStonks Apr 11, 2024 10:37AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Poor longs getting knocked out again. 26 and then 24 follow
Reply
1 0
Report
amt hun
amt hun Mar 07, 2024 8:35AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I bet the Chinese and the Indian investors are piling up the shares like crazy at this price.
Reply
9 1
Report
Luca ZeStonks
Luca ZeStonks Mar 07, 2024 3:56AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Next knock out 25 then 24, then from July recovery
Reply
2 1
Report
Luca ZeStonks
Luca ZeStonks Mar 05, 2024 8:40AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
27 knock out coming soon
Reply
2 1
Report
Luca ZeStonks
Luca ZeStonks Mar 05, 2024 8:40AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
KNOCKED OUT BOOM
Reply
1 0
Report
Luu Mrv
Luu Mrv Mar 05, 2024 5:48AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
from ext week will rise over 30. ;)
Reply
0 2
Report
Luca ZeStonks
Luca ZeStonks Feb 29, 2024 8:13AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Next trial loss lets go to 24 euros
Reply
3 0
Report
ollie susnea
ollie susnea Feb 29, 2024 8:13AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
then I will buy
Reply
1 0
Report
amt hun
amt hun Feb 29, 2024 8:13AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
bayer is winning the overwhelming majority of the trials, but those don't make it to the news.
Reply
1 0
Report
Luca ZeStonks
Luca ZeStonks Feb 29, 2024 8:13AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
5k+ lawsuits to go
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email